ICON Public Limited Company

NasdaqGS:ICLR

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

Ireland

Market Cap

USD 13.67 B

Share Price

USD 175.83

Avg Daily Volume

1,342,175

Change (1 day)

0.07%

Change (1 year)

-45.11%

Change (YTD)

-16.16%

ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 16.97%

ICON Public Limited Company EBITDA Margin is 16.97% for the Trailing 12 Months (TTM) ending June 30, 2025, a -15.02% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 19.97%, a 5.36% change year over year.
ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 18.96%, a 25.89% change year over year.
ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 15.06%, a -11.06% change year over year.
ICON Public Limited Company EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 16.93%, a 1.20% change year over year.